Clinical Trial Update: Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cycle therapy versus sequential therapy with romosozumab and denosumab in postmenopausal osteoporosis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (Prolia/Xgeva) (denosumab)
• Romosozumab (Evenity) (romosozumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Osteoporosis, Osteoporosis Postmenopausal | Phase 4 | Status: RECRUITING